BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 11818480)

  • 41. Role of allogeneic transplantation in chronic myeloid leukemia.
    Heim D; Gratwohl A
    Expert Rev Hematol; 2008 Oct; 1(1):41-50. PubMed ID: 21083006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Introduction: chronic myelogenous leukemia leading advanced clinical oncology].
    Asano S
    Nihon Rinsho; 2001 Dec; 59(12):2309-10. PubMed ID: 11766330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Signal transduction inhibition: changing paradigms in cancer care.
    Schiffer CA
    Semin Oncol; 2001 Oct; 28(5 Suppl 17):34-9. PubMed ID: 11740805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evidence-based therapy for chronic leukemia].
    Okamoto S
    Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):979-85. PubMed ID: 12866442
    [No Abstract]   [Full Text] [Related]  

  • 45. [Chronic myeloid leukemia].
    Hochhaus A
    Dtsch Med Wochenschr; 2011 Oct; 136(40):2007-10. PubMed ID: 21960328
    [No Abstract]   [Full Text] [Related]  

  • 46. Pretransplant imatinib can improve the outcome of nonmyeloablative stem cell transplantation without increasing the morbidity in Philadelphia chromosome-positive chronic myeloid leukemia.
    Kim DW; Chung YJ; Lee S; Kim YJ; Chung NG; Kim JA; Oh IH; Kim TG; Kim YL; Goh HG; Kim SH; Cho B; Kim HJ; Min CK; Lee JW; Jin JY; Han CW; Kim JW; Min WS; Kim HK; Kim CC; Kim HJ
    Leukemia; 2004 Nov; 18(11):1907-9. PubMed ID: 15356641
    [No Abstract]   [Full Text] [Related]  

  • 47. [The management of chronic phase CML].
    Ohnishi K
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():499-504. PubMed ID: 17474455
    [No Abstract]   [Full Text] [Related]  

  • 48. [New perspective in the treatment of chronic myeloid leukemia? gene silencing therapy].
    Kiss-Tóth É; Juhászné Szalai A; Koska P; Szebeni J; Kiss-Tóth E; Barkai L; Fodor B
    Magy Onkol; 2012 Mar; 56(1):16-22. PubMed ID: 22403758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic myelogenous leukemia in chronic phase.
    Kurzrock R; Kantarjian H; Talpaz M
    Curr Treat Options Oncol; 2001 Jun; 2(3):245-52. PubMed ID: 12057124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thriving with chronic myeloid leukaemia.
    Morris RH
    Lancet; 2001 Dec; 358 Suppl():S12. PubMed ID: 11784561
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hematologic malignancies/ pediatric malignancies-chronic myeloid leukemia].
    Usui N
    Gan To Kagaku Ryoho; 2011 May; 38(5):744. PubMed ID: 21717663
    [No Abstract]   [Full Text] [Related]  

  • 52. Tyrosine kinase inhibitors in chronic myeloid leukemia.
    Sawyers CL; Druker B
    Cancer J Sci Am; 1999; 5(2):63-9. PubMed ID: 10198725
    [No Abstract]   [Full Text] [Related]  

  • 53. Chronic myeloid leukemia: diagnosis and treatment.
    Quintás-Cardama A; Cortes JE
    Mayo Clin Proc; 2006 Jul; 81(7):973-88. PubMed ID: 16835977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Allogeneic stem cell transplantation].
    Sawafuji K; Okamoto S
    Nihon Rinsho; 2001 Dec; 59(12):2375-82. PubMed ID: 11766342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New treatment approaches for chronic myelogenous leukemia.
    Faderl S; Kantarjian HM; Talpaz M; O'Brien S
    Semin Oncol; 2000 Oct; 27(5):578-86. PubMed ID: 11049024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A limited but necessary indication of stem cell transplantation for chronic myelogeneous leukemia in the era of tyrosine kinase inhibitors.
    Imataki O
    Transplantation; 2014 Jan; 97(1):e4-5. PubMed ID: 24374768
    [No Abstract]   [Full Text] [Related]  

  • 57. Update on therapy for chronic myelogenous leukemia.
    Weinberger BB
    J La State Med Soc; 1994 Aug; 146(8):341-3. PubMed ID: 7930864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stem cell transplantation in patients with chronic myelogenous leukemia: when should it be used?
    Mauro MJ; Maziarz RT
    Mayo Clin Proc; 2006 Mar; 81(3):404-16. PubMed ID: 16529146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The role of allogenic hematopoietic stem cell transplantation for chronic myeloid leukemia in imatinib era].
    Yano S
    Gan To Kagaku Ryoho; 2011 May; 38(5):759-64. PubMed ID: 21714206
    [No Abstract]   [Full Text] [Related]  

  • 60. [Tyrosine kinase inhibitors (TKI): a new revolution in the treatment of chronic myeloid leukemia (CML)].
    Avilés-Vázquez S; Chávez-González A; Mayani H
    Gac Med Mex; 2013; 149(6):646-54. PubMed ID: 24276188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.